TB-500 · DOSSIER

TB-500

Thymosin Beta-4 · Tβ4 · Peptide · 43 AS
LEGAL DE · NOT APPROVEDEVIDENCE · PRECLINICAL3 STUDIESWADA · S2
SUMMARY

In preclinical models it promoted cell migration and tissue repair in muscle, heart and wounds.

FIG.01 — SIGNAL CHAIN
Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES · ~4963 Da
EVIDENCE LEVELSPROVEN IN HUMANSANIMAL MODELS ONLYMECHANISM ONLYUNPROVEN IN HUMANS
01

What it does in the body

Findings, each with its evidence level — animal data kept visibly apart from what's unproven in humans.

Faster recovery

In preclinical models it promoted cell migration and tissue repair in muscle, heart and wounds.

ANIMAL MODELS ONLY
New blood vessels

Steers the cell-scaffold protein actin, thereby influencing blood-vessel formation and inflammation.

MECHANISM ONLY
Studied for heart repair

Thymosin β4 has been studied for cardiac-muscle regeneration after heart attack — so far only preclinical.

ANIMAL MODELS ONLY
Unproven in humans

No published human studies exist for synthetic TB-500; eye studies with thymosin β4 had mixed results.

UNPROVEN IN HUMANS
02

Mechanism of action

What TB-500 does in the body — step by step.

01

TB-500 (as a synthetic analog of thymosin beta-4, a naturally occurring peptide) interacts with G-actin and regulates actin polymerisation in cells.

02

Thymosin beta-4 is expressed endogenously in high concentrations in platelets and other cells and is involved in cell migration, proliferation and differentiation.

03

Preclinical studies suggest interactions with angiogenic and inflammation-modulating signalling pathways.

03

Research status

How far along is the evidence?

PRECLINICALEARLY CLINICAL STUDIESCLINICALLY ESTABLISHED
Thymosin beta-4 has been investigated in the context of cardiac muscle regeneration after myocardial infarction (preclinical models) as well as wound healing and neuroprotection.
Thymosin beta-4 has been investigated in the context of cardiac muscle regeneration after myocardial infarction (preclinical models) as well as wound healing and neuroprotection.
Clinical studies of thymosin beta-4 (Regentec/RegeneRx) were conducted for eye conditions (dry eye, neurotrophic keratitis), with mixed results.
For the synthetic TB-500 variant (trade name, research chemical), no published clinical human studies exist.
Cardiovascular applications are at an early preclinical stage.
04

Known risks

Without human data, safety statements are limited. What is known:

01
No controlled human studies of synthetic TB-500 — safety profile not established
02
Theoretical risk of uncontrolled cell differentiation (growth-factor activity)
03
Unknown interactions with existing heart conditions
04
Product quality cannot be verified from unapproved sources
05
WADA ban: doping-relevant in competitive sport
05

Cited studies

Chronological — links lead to the source.

2016
Thymosin Beta 4: A Multi-Functional Regenerative Peptide. Basic Properties and Clinical Applications
PubMed 26804375 →
2017
Thymosin beta-4 and the heart: Protective, regenerative, or both?
PubMed 27616701 →
2018
Phase 2 trial of thymosin beta4 for the treatment of neurotrophic keratopathy
PubMed 29382630 →
06

Frequently asked questions

What is TB-500?+

TB-500 (as a synthetic analog of thymosin beta-4, a naturally occurring peptide) interacts with G-actin and regulates actin polymerisation in cells.

What type of peptide is TB-500?+

TB-500 belongs to the Thymosin class.

What is TB-500 used for?+

In research, TB-500 has primarily been investigated in the context of: Recovery, Muscle growth, Immunomodulation. These are research findings (evidence: preclinical), not proven benefits in humans and not a usage recommendation.

Is TB-500 legal in Germany?+

TB-500 is not approved as a medicine in Germany. Obtaining it outside clinical studies is legally problematic.

Is TB-500 FDA-approved / legal in the US?+

No. TB-500 is not FDA-approved as a drug in the US; it is mostly sold as a research chemical and not for human consumption.

Is TB-500 legal in Canada?+

No. TB-500 is not authorized by Health Canada and not intended for human consumption.

Where can I buy TB-500?+

Peptica sells nothing and names no sources. TB-500 is "not approved" in Germany; obtaining unapproved substances outside clinical studies is illegal and carries quality and safety risks.

What is the dosage of TB-500?+

Peptica publishes no dosing. There are no approved dosing guidelines for TB-500; figures circulating online stem from animal studies or anecdote, not from validated human protocols. This is not medical advice.

Is TB-500 banned in sport (WADA)?+

Yes. TB-500 is on the WADA Prohibited List and is therefore banned in competitive sport.

What are the known risks of TB-500?+

Documented risks include: No controlled human studies of synthetic TB-500 — safety profile not established; Theoretical risk of uncontrolled cell differentiation (growth-factor activity). This is not a complete safety assessment and not medical advice — see the risks section for the full list.

How well researched is TB-500?+

The evidence is classified as “preclinical”. 3 studies are cited on this page.

What is the molecular weight of TB-500?+

TB-500 has a molar mass of about 4963 Da.

Which peptides are related to TB-500?+

Closely related entries: BPC-157. A direct side-by-side comparison is available via the compare function.

07

Dossier

Legal · Structure · Sources.

LEGAL STATUS BY REGION
Germanynot approved

Thymosin beta-4 and TB-500 are on the WADA Prohibited List (section S2). The substance is not approved as a medicine in the EU. Thymosin beta-4 is used in veterinary medicine in some countries (e.g. Australia) for horses; these approvals do not apply to human use. Legal status on import is unclear — conservative assessment: not to be obtained.

Legal status varies by country and can change. This is not legal advice.

STRUCTURE & MOLECULE
H₂NAc-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGESCOOH
43
AMINO ACIDS
~4963
MOL. WEIGHT (Da)
No published human pharmacokinetic data
HALF-LIFE
SOURCES & EXTERNAL DATABASES

Methodology: Peptica compiles publicly available studies and regulatory information and assigns each statement an evidence level. Not medical advice. No warranty.

RELATED PEPTIDES & FURTHER READING
08

Community notes

Note: These posts are user opinions and not medical advice. Posts containing dosages, therapeutic claims or purchase recommendations are removed. All entries are manually reviewed before publication.
This page is intended solely for factual, scientifically oriented information. No medical advice · no dosage or usage recommendations · no claims of efficacy · no substitute for medical consultation. Peptica sells no substances. Partner links are marked as advertising; Peptica may earn a commission. © 2026 Peptica · Issue 01